_04e99b61.png)
Lot GRCG15-062026-1
Current12.5mg/2.5mgFreedom Diagnostics Testing · Tested 2026-06-14 · Accession Nura2606110393
≥99% PurityRUO
Current Lot: GRCG15-062026-1
Analytical Standard
Triple Incretin + Amylin Analog Co-Formulation
GLP-3R / CAG 12.5mg/2.5mg
A dual-component compound combining GLP-3R with long-acting amylin receptor agonist CAG for multi-pathway satiety and metabolic rate research.
Available strength
Bundle & Save
Volume pricing applies automatically to every compound.
Selected price
$105.00
Order within · ships Monday
Orders placed now ship on Monday. Same-day dispatch before 3:00 PM ET · Monday–Friday
Cutoff is calculated in Eastern Time (ET).
Same-day dispatch window
Place an order before the weekday cutoff for same-day dispatch.
Monday–Friday fulfillment
Orders placed after cutoff or during the weekend move to the next business-day dispatch window.
Free shipping on orders of $200+
Insured 2nd Day Air is free when your product total after discounts is $200 or more; otherwise $12. Shipping is shown before order placement.
Lot-specific COA access
Free shipping $200+
Account-only checkout
GLP-3R / CAG description
Permits laboratory investigation of coordinated amylin and incretin receptor signaling in cell and tissue models.
Specifications
- Form
- Lyophilized powder
- Available strengths
- 12.5mg/2.5mg
- Purity specification
- ≥99%
- Intended use
- Laboratory research use only. Not for human or veterinary use.
Third-party laboratory verification
Every COA on Record
Every verified batch on record is listed with the most recent test date first.
Filter by labeled strength
Showing 2 of 2 records.
Lot RETCAG25J
12.5mg/2.5mgFreedom Diagnostics Testing · Tested 2026-01-08 · Accession Nura2601070084